Brean Murray Carret & Co. Maintains a 'Buy' on Medivation (MDVN); Adjusting Numbers on Xtandi Approval
Tweet Send to a Friend
Brean Murray Carret & Co. maintains a 'Buy' on Medivation (NASDAQ: MDVN) price target of $125.00 (from $105.00).
Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
